Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine vs Norepinephrine in Septic Shock
NCT00481442Phase 2Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of phenylephrine in septic shock (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Systemic and regional hemodynamics at 24 hours. Started Jan 2007; status: completed.
02
Drugs
phenylephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00481442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481442.